Immunocore Holdings Ltd (IMCR) — Cash Flow Reinvestment Rate
Immunocore Holdings Ltd (IMCR) has a Cash Flow Reinvestment Rate of 1.19x as of June 2025, reinvesting $30.83 Million (capex $414.00K plus investments $-30.41 Million) from operating cash flow of $25.96 Million. Explore Immunocore Holdings Ltd (IMCR) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Immunocore Holdings Ltd Cash Flow Reinvestment Rate (2023–2024)
Historical reinvestment intensity for Immunocore Holdings Ltd across 2 annual periods. Also explore balance sheet size of Immunocore Holdings Ltd for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Immunocore Holdings Ltd (2023–2024)
Year-by-year capital reinvestment analysis for Immunocore Holdings Ltd. For live market cap and broader valuation context, see Immunocore Holdings Ltd (IMCR) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 13.83x | $360.30 Million | $26.06 Million | $5.17 Million | ▲ +298.1% |
| 2023 | 3.47x | $10.21 Million | $2.94 Million | $5.42 Million | — |